Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Alofisel (darvadstrocel) for the Treatment of Complex Perianal Fistulas in Crohn’s Disease

Drug (Brand / Generic)

Alofisel® / darvadstrocel

Company / Licensee

TiGenix NV / Takeda Pharmaceutical Company

Therapy Class

Allogeneic stem cell therapy

Current Indication

Complex perianal fistulas in Crohn’s Disease

Market Sector

Gastroenterology

Development Status

Approved in Europe
Expand
Close
Close
Close

Go Top